NEURODEGENERATIVE DISEASES
Clinical trials for NEURODEGENERATIVE DISEASES explained in plain language.
Never miss a new study
Get alerted when new NEURODEGENERATIVE DISEASES trials appear
Sign up with your email to follow new studies for NEURODEGENERATIVE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets brain inflammation in early Alzheimer's patients
Disease control CompletedThis Phase 2 study tested whether XPro1595 could help people with early Alzheimer's disease who show signs of brain inflammation. The trial involved 208 participants aged 50-85 who received either the drug or a placebo for 24 weeks. Researchers measured changes in memory, thinkin…
Matched conditions: NEURODEGENERATIVE DISEASES
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Extended trial tests promising drug for genetic muscle disease
Disease control CompletedThis study continued testing an experimental drug called AOC 1001 in adults with myotonic dystrophy type 1, a genetic muscle-wasting disease. It followed 37 participants from a previous trial to check long-term safety and see if the drug continues to work when given every 8 weeks…
Matched conditions: NEURODEGENERATIVE DISEASES
Phase: PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Sound waves could spot rare nerve disease
Diagnosis CompletedThis study tested whether a simple ultrasound scan could help doctors diagnose CANVAS, a rare genetic disorder that causes balance problems and nerve damage. Researchers used ultrasound to measure the size of nerves in the arms and legs of 35 patients with confirmed CANVAS. The g…
Matched conditions: NEURODEGENERATIVE DISEASES
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Diagnosis
Last updated Apr 03, 2026 14:42 UTC
-
Can a daily pill boost brainpower? scientists test NAD+ in women
Knowledge-focused CompletedThis study tested whether a daily NAD+ supplement could improve thinking skills or change certain health markers in the blood. It involved 53 healthy women aged 40-80 who took either the supplement or a placebo pill for four weeks. Researchers measured participants' memory and th…
Matched conditions: NEURODEGENERATIVE DISEASES
Phase: NA • Sponsor: University of Rhode Island • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC